Thevetin B

Thevetin B

SCHEMBL29463277

CO[C@@H]1[C@@H](O)[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)C(C5=CC(=O)OC5)CC[C@]43O)C2)O[C@@H](C)[C@H]1O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATP1A1 P05023 11/20 0.80
ATP1B1 P05026 11/20 0.80
ATP1A3 P13637 11/20 0.80
ATP1B2 P14415 11/20 0.80
ATP1A2 P50993 11/20 0.80
ATP1B3 P54709 11/20 0.80
FXYD2 P54710 11/20 0.80
ATP1A4 Q13733 11/20 0.80
SMN1; SMN2 Q16637 2/20 0.74
LMNA P02545 1/20 0.74
TP53 P04637 1/20 0.74
HBB P68871 1/20 0.74
PAX8 Q06710 1/20 0.69
NPC1 O15118 1/20 0.68
RAB9A P51151 1/20 0.68
HIF1A Q16665 1/20 0.64
EPAS1 Q99814 1/20 0.64
MAPT P10636 1/20 0.64
RELA Q04206 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thevetin B SCHEMBL29389027 1.00 ATP1A1 (0.80) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Thevetin B SCHEMBL869661 1.00 ATP1A1 (0.80) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Thevetin B SCHEMBL12556692 1.00 ATP1A1 (0.80) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL29413165 0.96 ATP1A1 (0.79) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Uzarin SCHEMBL702463 0.93 ATP1A1 (0.92) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Digitoxigenin Gentiobioside SCHEMBL702464 0.93 ATP1A1 (0.92) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Digitoxigenin Gentiobioside SCHEMBL1652279 0.93 ATP1A1 (0.92) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL30500612 0.92 ATP1A1 (0.85) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL14648704 0.92 SMN1; SMN2 (0.75) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL867986 0.92 SMN1; SMN2 (0.75) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351819-B2 Method for removing undifferentiated pluripotent stem cells ACADEMIA SINICA (TW) 2025-07-08 US disclosed
CN-114150014-B Method for creating corn dwarf material based on ZmEMF2b/2-2 gene 吉林省农业科学院 2023-05-16 CN disclosed
CN-114177189-A Application of thebaine glucoside as antitumor drug 天津中医药大学 2022-03-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12351819-B2 Method for removing undifferentiated pluripotent stem cells ALPG, UGGT1, GYPA ATP1A1 212/4885ATP1B1 88/4885ATP1A3 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.